191 related articles for article (PubMed ID: 32868368)
21. Clinical management of COVID-19: Experiences of the COVID-19 epidemic from Groote Schuur Hospital, Cape Town, South Africa.
Mendelson M; Boloko L; Boutall A; Cairncross L; Calligaro G; Coccia C; Dave JA; De Villiers M; Dlamini S; Frankenfeld P; Gina P; Gule MV; Hoare J; Hofmeyr R; Hsiao M; Joubert I; Kahn T; Krause R; Kroopman A; Levin D; Maughan D; Mazondwa S; Meintjes G; Nordien R; Ntusi N; Papavarnavas N; Peter J; Pickard H; Raubenheimer P; Said-Hartley Q; Singh P; Wasserman S; Schuur Hospital Covid-Response Team OBOTG
S Afr Med J; 2020 Aug; 110(10):973-981. PubMed ID: 33205723
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics and Outcomes of 421 Patients With Coronavirus Disease 2019 Treated in a Mobile Cabin Hospital.
Wang W; Xin C; Xiong Z; Yan X; Cai Y; Zhou K; Xie C; Zhang T; Wu X; Liu K; Li Z; Chen J
Chest; 2020 Sep; 158(3):939-946. PubMed ID: 32437696
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics associated with mortality of COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa.
Nyasulu PS; Ayele BT; Koegelenberg CF; Irusen E; Lalla U; Davids R; Chothia Y; Retief F; Johnson M; Venter S; Pillay R; Prozesky H; Taljaard J; Parker A; Decloedt EH; Jordan P; Lahri S; Moosa MR; Moolla MS; Yalew A; Baines N; Maud P; Louw E; Nortje A; Dunbar R; Sigwadhi LN; Ngah VD; Tamuzi JL; Zemlin A; Chapanduka Z; English R; Allwood BW
PLoS One; 2022; 17(12):e0279565. PubMed ID: 36584024
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
25. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
26. Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England.
de Lusignan S; Lopez Bernal J; Zambon M; Akinyemi O; Amirthalingam G; Andrews N; Borrow R; Byford R; Charlett A; Dabrera G; Ellis J; Elliot AJ; Feher M; Ferreira F; Krajenbrink E; Leach J; Linley E; Liyanage H; Okusi C; Ramsay M; Smith G; Sherlock J; Thomas N; Tripathy M; Williams J; Howsam G; Joy M; Hobbs R
JMIR Public Health Surveill; 2020 Apr; 6(2):e18606. PubMed ID: 32240095
[TBL] [Abstract][Full Text] [Related]
27. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study.
Karagiannidis C; Mostert C; Hentschker C; Voshaar T; Malzahn J; Schillinger G; Klauber J; Janssens U; Marx G; Weber-Carstens S; Kluge S; Pfeifer M; Grabenhenrich L; Welte T; Busse R
Lancet Respir Med; 2020 Sep; 8(9):853-862. PubMed ID: 32735842
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.
Xie J; Wu W; Li S; Hu Y; Hu M; Li J; Yang Y; Huang T; Zheng K; Wang Y; Kang H; Huang Y; Jiang L; Zhang W; Zhong M; Sang L; Zheng X; Pan C; Zheng R; Li X; Tong Z; Qiu H; Du B
Intensive Care Med; 2020 Oct; 46(10):1863-1872. PubMed ID: 32816098
[TBL] [Abstract][Full Text] [Related]
29. Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Hanna CR; Blyth KG; Burley G; Carmichael S; Evans C; Hinsley S; Khadra I; Khoo S; Lewsley LA; Jones RR; Sharma R; Taladriz-Sender A; Thomson EC; Scott JT
Trials; 2020 Nov; 21(1):935. PubMed ID: 33213530
[TBL] [Abstract][Full Text] [Related]
30. Epidemiological & clinical characteristics & early outcome of COVID-19 patients in a tertiary care teaching hospital in India: A preliminary analysis.
Kayina CA; Haritha D; Soni L; Behera S; Nair PR; Gouri M; Girish K; Deeparaj L; Maitra S; Anand RK; Ray BR; Baidya DK; Subramaniam R
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):100-104. PubMed ID: 32811801
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 emergency response assessment study: a prospective longitudinal survey of frontline doctors in the UK and Ireland: study protocol.
Roberts T; Daniels J; Hulme W; Horner D; Lyttle MD; Samuel K; Graham B; Hirst R; Reynard C; Barrett M; Carlton E
BMJ Open; 2020 Aug; 10(8):e039851. PubMed ID: 32788191
[TBL] [Abstract][Full Text] [Related]
32. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study.
Meredith LW; Hamilton WL; Warne B; Houldcroft CJ; Hosmillo M; Jahun AS; Curran MD; Parmar S; Caller LG; Caddy SL; Khokhar FA; Yakovleva A; Hall G; Feltwell T; Forrest S; Sridhar S; Weekes MP; Baker S; Brown N; Moore E; Popay A; Roddick I; Reacher M; Gouliouris T; Peacock SJ; Dougan G; Török ME; Goodfellow I
Lancet Infect Dis; 2020 Nov; 20(11):1263-1272. PubMed ID: 32679081
[TBL] [Abstract][Full Text] [Related]
33. COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020).
COVID-19 National Incident Room Surveillance Team
Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32517645
[TBL] [Abstract][Full Text] [Related]
34. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.
Frontera J; Mainali S; Fink EL; Robertson CL; Schober M; Ziai W; Menon D; Kochanek PM; Suarez JI; Helbok R; McNett M; Chou SH;
Neurocrit Care; 2020 Aug; 33(1):25-34. PubMed ID: 32445105
[TBL] [Abstract][Full Text] [Related]
35. Leadership and early strategic response to the SARS-CoV-2 pandemic at a COVID-19 designated hospital in South Africa.
Parker A; Karamchand S; Schrueder N; Lahri S; Rabie H; Aucamp A; Abrahams R; Ciapparelli P; Erasmus DS; Cotton MF; Lalla U; Leisegang R; Meintjes J; Mistry R; Moosa MR; Mowlana A; Koegelenberg CFN; Prozesky H; Smith W; Van Schalkwyk M; Taljaard JJ
S Afr Med J; 2020 Apr; 110(6):463-465. PubMed ID: 32880553
[TBL] [Abstract][Full Text] [Related]
36. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
[TBL] [Abstract][Full Text] [Related]
37. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
[TBL] [Abstract][Full Text] [Related]
38. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
40. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.
Li J; Zhang C; Wu Z; Wang G; Zhao H
Trials; 2020 Jun; 21(1):488. PubMed ID: 32503657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
